Shares of the company fell more than 7% in premarket trading on Thursday. Meanwhile, shares of rival Novo Nordisk, which is also working to bring an obesity pill to the market, jumped more than 7% on Thursday.
Eli Lilly Shares Rocked After Weight Loss Pill Disappoints